Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response.
BACKGROUND
Sepsis remains a substantial risk after surgery or other trauma. Macrophage dysfunction, as a component of immune suppression seen during trauma and sepsis, appears to be one of the contributing factors to morbidity and mortality. However, whereas it is known that the ability of macrophages to present antigen and express major histocompatibility complex MHC class II molecules is decreased during sepsis, it is not known to what extent this is associated with the loss of co-stimulatory receptor expression. Our objectives in this study were, therefore, to determine if the expression of co-stimulatory molecules, such as CD40, CD80, or CD86, on peritoneal/splenic/liver macrophages were altered by sepsis (cecal ligation [CL] and puncture [CLP] or necrotic tissue injury (CL) alone; and to establish the contribution of such changes to the response to septic challenge using mice that are deficient in these receptors.


METHODS
To address our first objective, male C3H/HeN mice were subjected to CLP, CL, or sham (n = four to six mice/group), and the adherent macrophages were isolated from the peritoneum, spleen, or liver at 24 h post-insult. The macrophages were then analyzed by flow cytometry for their ex vivo expression of CD40, CD80, CD86, and/or MHC II.


RESULTS
The expression of CD86 and MHC II, but not CD40 or CD80, were significantly decreased on peritoneal macrophages after the onset of sepsis or CL alone. In addition, CD40 expression was significantly increased in Kupffer cells after sepsis. Alternatively, splenic macrophages from septic or CL mice did not show changes in the expression of CD80, CD86, or CD40. To the degree that the loss of CD86 expression might contribute to the changes reported in macrophage function in septic mice, we subsequently examined the effects of CLP on CD86 -/- mice. Interestingly, we found that, unlike the background controls, neither the serum IL-10 concentrations nor the IL-10 release capacity of peritoneal macrophages from septic CD86 -/- mice were increased.


CONCLUSIONS
Together, these data suggest a potential role for the co-stimulatory receptor CD86/B7-2 beyond that of simply promoting competent antigen presentation to T-cells, but also as a regulator of the anti-inflammatory IL-10 response. Such a role may implicate the latter response in the development of sepsis-induced immune dysfunction.
Newton
Sarah
S
Division of Surgical Research, Department of Surgery, Lifespan/Rhode Island Hospital, Brown University School of Medicine, Providence, RI 02903, USA.
Ding
Yanli
Y
Chung
Chun-Shiang
CS
Chen
Yaping
Y
Lomas-Neira
Joanne L
JL
Ayala
Alfred
A
D000818:Animals; D015703:Antigens, CD / Q000276:immunology*; D018122:B7-1 Antigen / Q000276:immunology; D051940:B7-2 Antigen; D019013:CD40 Antigens / Q000276:immunology; D005802:Genes, MHC Class II / Q000276:immunology; D007154:Immune System Diseases / Q000276:immunology*; D016753:Interleukin-10 / Q000276:immunology*; D008264:Macrophages / Q000276:immunology*; D008297:Male; D008562:Membrane Glycoproteins / Q000276:immunology*; D051379:Mice; D023421:Models, Animal; D010538:Peritonitis / Q000150:complications / Q000276:immunology; D018805:Sepsis / Q000276:immunology*
D015703:Antigens, CD; D018122:B7-1 Antigen; D051940:B7-2 Antigen; D019013:CD40 Antigens; C497965:Cd86 protein, mouse; D008562:Membrane Glycoproteins; D016753:Interleukin-10
Cytokine. 1992 Jan;4(1):66-75
1319764
Surgery. 1985 Aug;98(2):199-206
3161195
J Immunol. 1995 Aug 15;155(4):2222-9
7636269
Crit Care Med. 2000 Aug;28(8):2949-55
10966277
Eur J Immunol. 1998 Apr;28(4):1417-25
9565382
J Immunol. 1999 Jan 1;162(1):392-9
9886412
Eur J Immunol. 2002 Jun;32(6):1764-72
12115660
Immunology. 1990 May;70(1):33-9
2354861
Infect Immun. 1996 Nov;64(11):4733-8
8890233
EMBO J. 1998 Feb 16;17(4):1006-18
9463379
Arch Surg. 1991 Feb;126(2):253-7; discussion 257-8
1993000
Shock. 2002 Jun;17(6):463-7
12069181
Int Immunol. 1999 Mar;11(3):341-9
10221646
Crit Care Med. 2003 Jan;31(1):34-8
12544990
Annu Rev Immunol. 2001;19:225-52
11244036
Crit Care Med. 2002 May;30(5):1015-23
12006796
Crit Care Med. 2001 Jul;29(7):1303-10
11445675
Arch Surg. 1993 Jan;128(1):89-94; discussion 94-5
8418786
Eur J Immunol. 2001 May;31(5):1400-9
11466703
J Trauma. 1996 Apr;40(4):568-73; discussion 573-4
8614034
J Immunol. 1991 Dec 15;147(12):4147-54
1753090
J Immunol. 1995 Jan 1;154(1):97-105
7527824
Crit Care. 2002 Dec;6 Suppl 3:S1-18
12720570
Am J Pathol. 2000 Aug;157(2):473-84
10934151
J Surg Res. 1994 Jun;56(6):579-85
8015314
Nat Struct Biol. 1997 Apr;4(4):311-6
9095200
J Lab Clin Med. 2000 Feb;135(2):153-60
10695660
Shock. 1994 Feb;1(2):130-4
7749931
Surgery. 1999 Aug;126(2):378-83
10455909
Shock. 1996;6 Suppl 1:S27-38
8828095
Shock. 1996 Feb;5(2):79-90
8705394
Annu Rev Immunol. 1998;16:111-35
9597126
Crit Care Med. 2002 Jan;30(1 Supp):S58-S63
11839946
Circ Shock. 1992 Mar;36(3):191-9
1611704
Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E433-7
12857678
Transplantation. 1998 Jul 15;66(1):14-20
9679816
Immunology. 1998 Jul;94(3):417-23
9767426
Mt Sinai J Med. 2001 May;68(3):160-6
11373688